A. Stavraka

Receptor scintigraphy of non-neuroendocrine cancers with In-111 pentetreotide.

L. Vlahos, N. Vitoratos, A. Rassidakis, 1997, Hybridoma.

Comparison of In-111 pentetreotide, Tc-99m (V)DMSA and I-123 mlBG scintimaging in neural crest tumors.

L. Vlahos, G. Limouris, A. Stavraka, 1997, Anticancer research.

Radionuclide Therapy of Painful Bone Metastases—A Comparative Study Between Consecutive Radionuclide Infusions, Combination With Chemotherapy, and Radionuclide Infusions Alone

A. Gouliamos, G. Limouris, Panagiotis A. Sideras, 2013, The American journal of hospice & palliative care.

Pharmacokinetics and Dosimetry after Combined Application of Sr-89 Chloride and Re-186-HEDP in Bone Metastases

L. Vlahos, G. Limouris, A. Manetou, 1997 .

Prostate Osseous Metastases: Evaluation of the Combined Application of Disodium Pamidronate/89Sr-Chloride/186Re-HEDP

L. Vlahos, S. K. Shukla, G. Limouris, 1997 .

99Tcm (V) DMSA and 111In Pentetreotide in the Detection of Malignancies

L. Vlahos, S. K. Shukla, G. Limouris, 1995 .

Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases

L. Vlahos, A. Chatziioannou, D. Mourikis, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Gastric emptying time, not enterogastric reflux, is related to symptoms after upper gastrointestinal/biliary surgery.

C. Frantzides, A. Madan, D. Apostolopoulos, 2002, American journal of surgery.

Radionuclide Visualization of Acute Occlusive and Nonocclusive Intestinal Ischemia

C. Frantzides, R. Condon, C. Pissiotis, 1986, Annals of surgery.